MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ — Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round. The company is thrilled to welcome new medtech and angel investors, along with participation from previous backers, reinforcing their unwavering belief in Sparta’s mission.
Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
